CureVac (NASDAQ:CVAC) announced on Friday that the company and its partner, GSK (NYSE:GSK), are set to receive $740M and other payments, as Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have agreed to ...

CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on ...

Health and Human Services Secretary and long-time vaccine critic Robert F. Kennedy Junior’s decision to cancel $500 million ...

Fewer Kentucky kindergarten students have received the vaccines required to attend school, and data from the state's School ...

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac $740 million plus royalties to settle US legal disputes over Covid-19 vaccines, ...

Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...

On Wednesday, after the news that the HHS was terminating crucial vaccine development projects worth $500 million, Cassidy called the decision "unfortunate" in a post on the X social network. That’s a ...

GSK said it would receive $370 million as part of a U.S. patent settlement between CureVac and BioNTech related to messenger mRNA-based Covid-19 vaccines.

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued mRNA vaccines are ineffective to justify the Department of ...

Health Secretary Robert F. Kennedy Jr. announced plans on Tuesday to cancel 22 mRNA vaccine development contracts totaling nearly $500 million. The move follows a “comprehensive review of mRNA-related ...

German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long patent ...